Revenue
No reported data
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
Price—Loading quote
Net income
2010
2011
2012
2013
2014
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
Financial statements
| 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|
| Operating expenses | $672,162 | $18,911 | $1.2M | $757,935 | $2.1M |
| Operating income | −$672,162 | −$18,911 | −$1.2M | −$757,935 | −$2.1M |
| EBITDAderived | — | — | — | −$757,935 | −$2.0M |
| Net income | −$672,162 | −$18,911 | −$1.0M | $3.7M | −$1.1M |
| Basic EPSper diluted share | -$0.04 | $0.01 | -$0.11 | $0.42 | -$0.13 |
| Diluted EPSper diluted share | -$0.04 | $0.01 | -$0.11 | $0.40 | -$0.13 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 17, 2025Form 4 | CTT PHARMACEUTICAL HOLDINGS, INC.CEO | BuyCTTH | 8.3K | $0.06 | $498.00 | 7.85M |
| Nov 20, 2025Form 4 | CTT PHARMACEUTICAL HOLDINGS, INC.Director | BuyCTTH | 200.0K | $0.04 | $8.0K | 3.73M |
| Nov 20, 2025Form 4 | CTT PHARMACEUTICAL HOLDINGS, INC.CEO | BuyCTTH | 62.9K | $0.04 | $2.5K | 7.84M |
| Oct 31, 2025Form 4 | CTT PHARMACEUTICAL HOLDINGS, INC.CEO | BuyCTTH | 7.0K | $0.06 | $420.00 | 7.77M |
| Sep 23, 2025Form 4 | CTT PHARMACEUTICAL HOLDINGS, INC.CEO | BuyCTTH | 6.8K | $0.06 | $408.90 | 7.77M |